Results 61 to 70 of about 12,383 (215)

Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy

open access: yesCase Reports in Nephrology, 2020
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is designed to amplify an immunologic reaction against cancer cells.
Jessica Cruz-Whitley   +3 more
doaj   +1 more source

Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia [PDF]

open access: yes, 2014
BACKGROUND: Patients with X-linked agammaglobulinemia (XLA) develop immune-complex induced diseases such as nephropathy only rarely, presumably because their immunoglobulin (Ig) G concentration is low.
Akane Izu   +7 more
core   +2 more sources

Development of a Novel UPC (Urine Red Blood Cell Distribution, Proteinuria, and Serum Creatinine) Index to Differentiate Glomerular from Nonglomerular Hematuria

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 8, April 2026.
The study developed the UPC index by integrating urine red blood cell distribution (URD), urine protein strip, and serum creatinine to enhance the diagnostic accuracy for distinguishing glomerular from nonglomerular hematuria. The UPC index demonstrated superior performance (AUC 0.857) compared to conventional parameters, showing high sensitivity and ...
Hae In Bang   +4 more
wiley   +1 more source

The impact of reclassification of C3 predominant glomerulopathies on diagnostic accuracy, outcome and prognosis in patients with C3 glomerulonephritis

open access: yesBMC Nephrology, 2020
Background C3 glomerulonephritis is a recently described entity with heterogeneous histopathological features. This study was conducted to assess the effect of reclassification of C3 glomerulopathies on renal outcomes, mortality, and response to therapy.
P. Puri   +5 more
doaj   +1 more source

Membranoproliferative glomerulonephritis associated with type II cryoglobulinaemia in a renal transplant patient with hepatitis C [PDF]

open access: yes, 2014
The most common HCV-related nephropathy is membranoproliferative glomerulonephritis (MPGN), usually in the context of cryoglobulinaemia. The treatment of this entity is not consensual and represents a challenge to clinicians.
Almeida, M.   +6 more
core  

Immunologic aspects of the nephrotic syndrome [PDF]

open access: yes, 1973
The nephrotic syndrome is a clinical entity characterized by proteinuria, hypoalbuminemia, edema and hyperlipidemia. All the features of this syndrome are ultimately related to increased permeability of the glomerular capillary to protein.
Michael, Alfred F.   +6 more
core   +4 more sources

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection—General and Special Populations

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 945-954, April 2026.
Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak   +2 more
wiley   +1 more source

Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach

open access: yeseJHaem, 2023
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries. The association between CLL and glomerular disease (GD) is rare. The most frequent GD associated with CLL is membranoproliferative membranous glomerulonephritis (
Angela Rago   +3 more
doaj   +1 more source

De Novo Fibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C. [PDF]

open access: yes, 2013
Chronic hepatitis C viremia (HepC) has been associated with numerous renal manifestations both in native kidneys and in the setting of renal transplantation. Glomerulonephritis (GN) of the renal allograft in the setting of HepC most commonly manifests as
Chmielewski, Christine   +4 more
core   +3 more sources

Pediatric Non‐Lupus Full House Nephropathy: Case Report and Review of Literature

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Lupus nephritis is a severe manifestation of systemic lupus erythematosus (SLE) typically characterized by glomerular “full‐house” immunofluorescence. However, non‐lupus nephropathies may occasionally exhibit similar patterns, creating diagnostic uncertainty.
Mohammad Firoz Anjum   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy